JAIDS Journal of Acquired Immune Deficiency Syndromes 2013-05-01

Appropriateness of hydroxyethylcellulose gel as a placebo control in vaginal microbicide trials: a comparison of the two control arms of HPTN 035.

Barbra A Richardson, Cliff Kelly, Gita Ramjee, Thomas Fleming, Bonus Makanani, Sarah Roberts, Petina Musara, Nkhafwire Mkandawire, Thomas Moench, Anne Coletti, Lydia Soto-Torres, Salim A Karim

Index: J. Acquir. Immune Defic. Syndr. 63(1) , 120-5, (2013)

Full Text: HTML

Abstract

To compare the 2 control arms of HPTN 035 [a hydroxyethylcellulose (HEC) gel control arm and a no-gel control arm] to assess the behavioral effects associated with gel use and direct causal effects of the HEC gel on sexually transmitted infections (STIs), pregnancy, and genital safety.Randomized trial with 1 blinded (HEC gel) and 1 open-label (no-gel) control arms.HIV-uninfected, sexually active women were randomized into the HEC gel arm (n = 771) and into the no-gel arm (n = 772) in 5 countries. Participants in the HEC gel arm were instructed to insert the study gel intravaginally <1 hour before each vaginal sex act. Data on sexual behavior, adherence, safety, pregnancy, and STIs were collected quarterly for 12-30 months of follow-up.During follow-up, mean reported condom use in the past week was significantly higher in the no-gel arm (81% versus 70%, P < 0.001). There were no significant differences, after adjusting for this differential condom use, between the 2 arms in the rates of genital safety events, pregnancy outcomes, or STIs, including HIV-1.In this large randomized trial, we found no significant differences between the no-gel and HEC gel arms in the rates of genital safety events, pregnancy outcomes, or STIs. These results aid interpretation of the results of previous vaginal microbicide trials that used the HEC gel as a control. The HEC gel is suitable as a control for ongoing and future vaginal microbicide studies.